Cancer innovation has been a longstanding priority in the current administration. But sometimes overlooked is some of the nation’s most sophisticated lung cancer research underway at the Department of Veterans Affairs. This includes applying capacities like modernized electronic health records and artificial intelligence to support groundbreaking innovation. Dr. Michael Kelley, director of the National Precision Oncology Program, and Kenute Myrie, portfolio manager at the VA Office of Research and Development, discuss how the agency is advancing understanding of cancer and improving long-term health outcomes for veterans.
HealthCast
Season 3
Episode 24
27m listen
How VA is Leveraging Genomics and Big Data to Improve Lung Cancer Outcomes
Share
Lung cancer innovation at the agency is looking at technology to improve detection and treatment.
-
Dr. Michael Kelley National Program Director for Oncology VA -
Dr. Kenute Myrie Lead for Precision Oncology, Office of Research and Development VA
Related Content
-
GSA Reveals PQC Priorities to Secure Identity Management
Following a White House executive order, GSA's PQC priorities tackle digital identity and building access systems from quantum threats.
2m read -
Federal Cloud & Data Forum
The Federal Cloud & Data Forum 2027 brings together federal leaders for a government data conference on cloud modernization and trusted data infrastructure.
Washington, D.C. -
Federal AI Forum
The Federal AI Forum 2027 brings together federal AI leaders for an AI in government conference on responsible AI, data and workforce readiness.
Reston, VA -
Federal Tech Leaders Summit
The Federal Tech Leaders Summit 2027 brings together federal CIOs and CTOs at this government CIO conference on IT modernization, cybersecurity and AI.
Washington, D.C.
